Empirical Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Sell
1,950
-1,020
-34% -$211K 0.01% 793
2026
Q1
$667K Sell
2,970
-72
-2% -$17.9K 0.01% 468
2025
Q4
$733K Sell
3,042
-2,674
-47% -$684K 0.01% 401
2025
Q3
$1.56M Sell
5,716
-18,989
-77% -$5.19M 0.03% 272
2025
Q2
$6.37M Buy
24,705
+1,025
+4% +$245K 0.14% 114
2025
Q1
$5.3M Buy
+23,680
New +$5.53M 0.14% 127
2022
Q1
Sell
-1,901
Closed -$495K 538
2021
Q4
$495K Sell
1,901
-1,186
-38% -$308K 0.02% 342
2021
Q3
$814K Buy
3,087
+499
+19% +$136K 0.05% 222
2021
Q2
$638K Buy
2,588
+1,494
+137% +$314K 0.04% 253
2021
Q1
$212K Buy
+1,094
New +$219K 0.02% 367

Other funds holding RMD

Empirical Wealth Management's RMD Position: Q2 2026 in Review

Empirical Wealth Management reduced its ResMed (RMD) stake by 34% in Q2 2026, selling an estimated $211K and leaving 1,950 shares worth $380K. The position accounts for 0.01% of the portfolio, ranked #793.

Empirical Wealth Management first reported a position in RMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $6.37M in Q2 2025. 301 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Empirical Wealth Management held 1,950 shares of ResMed worth $380K as of Q2 2026.
  • Empirical Wealth Management sold 1,020 ResMed shares in Q2 2026, an estimated $211K.
  • ResMed made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #793 holding.
  • Empirical Wealth Management first reported a position in ResMed in Q1 2021 and has held it in 10 quarters since.
  • Empirical Wealth Management's ResMed position peaked at $6.37M in Q2 2025.
  • 301 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.